bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe

SAN JOSE, Calif.: SAN JOSE, Calif., June 29, 2021 /PRNewswire-PRWeb/ -- In the context of the global threat from Antimicrobial Resistance (AMR), clinicians need to receive faster antibiotic susceptibility test (AST) results and accurate interpretation, to enable timely and optimized patient intervention. In bloodstream infections, an urgent and often life-threatening...

Click to view original post